INSIDER · CIK 2123284
Antz Christoph Rudiger
Chief Executive Officer, Director at Veraxa Biotech AG - Post de-SPAC (VRXA)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$8KBought on the market
$0.00Sold on the market
1Companies
Aug 31, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 202616:10 | Aug 27, 2026 | VRXAVeraxa Biotech AG - Post de-SPAC | Chief Executive Officer, Director | P · Buy | $1.53 | +5,000 | 5,000 | New | +$8K | -93.8% | -26.1% |